Independent Recognition Reinforces Auragens' Position as a Global Leader in Regenerative Medicine
First organization to earn Life Sciences Review's "Stem Cell Treatment Center of the Year" award for two consecutive years, validating its integrated scientific, manufacturing, and clinical platform.
Auragens today announced it has been named Stem Cell Treatment Center of the Year 2026 by Life Sciences Review, becoming the first organization to receive the publication's highest distinction for two consecutive years.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260709190896/en/ Auragens Team
While the award recognizes excellence in patient care, it also reflects a broader transformation taking place within regenerative medicine—one in which scientific rigor, manufacturing quality, regulatory oversight, and integrated clinical delivery are becoming the defining characteristics of industry leadership.
